{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:12:06Z","timestamp":1791115926820,"version":"4.1.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,10]]},"DOI":"10.7759\/cureus.85712","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T16:25:43Z","timestamp":1749572743000},"source":"Crossref","is-referenced-by-count":1,"title":["Tranexamic Acid in Postpartum Hemorrhage Management: A Multinational Systematic Review of Efficacy and Safety in Both Vaginal and Cesarean Births"],"prefix":"10.7759","author":[{"given":"Nisreen","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say L","year":"2014","unstructured":"Say L, Chou D, Gemmill A, et al.. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014, 2:e323-33. 10.1016\/S2214-109X(14)70227-X","journal-title":"Lancet Glob Health"},{"key":"ref2","unstructured":"WHO recommendations for the prevention and treatment of postpartum haemorrhage. (2012). https.\/\/apps.who.int\/iris\/handle\/10665\/75411."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal death: a systematic review","volume":"367","author":"Khan KS","year":"2006","unstructured":"Khan KS, Wojdyla D, Say L, G\u00fclmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006, 367:1066-74. 10.1016\/S0140-6736(06)68397-9","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007412.pub5","article-title":"Active versus expectant management for women in the third stage of labour","volume":"2","author":"Begley CM","year":"2019","unstructured":"Begley CM, Gyte GM, Devane D, McGuire W, Weeks A, Biesty LM. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev. 2019, 2:CD007412. 10.1002\/14651858.CD007412.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001886.pub3","article-title":"Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion","author":"Henry DA","year":"2011","unstructured":"Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011, CD001886. 10.1002\/14651858.CD001886.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60278-X","article-title":"The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial","volume":"377","author":"CRASH-2 collaborators","year":"2011","unstructured":"CRASH-2 collaborators, Roberts I, Shakur H, et al.. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011, 377:1096-101. 10.1016\/S0140-6736(11)60278-X","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"WOMAN Trial Collaborators","year":"2017","unstructured":"WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017, 389:2105-16. 10.1016\/S0140-6736(17)30638-4","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2207419","article-title":"Tranexamic acid to prevent obstetrical hemorrhage after cesarean delivery","volume":"388","author":"Pacheco LD","year":"2023","unstructured":"Pacheco LD, Clifton RG, Saade GR, et al.. Tranexamic acid to prevent obstetrical hemorrhage after cesarean delivery. N Engl J Med. 2023, 388:1365-75. 10.1056\/NEJMoa2207419","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01749-5","article-title":"The effect of tranexamic acid on postpartum bleeding in women with moderate and severe anaemia (WOMAN-2): an international, randomised, double-blind, placebo-controlled trial","volume":"404","author":"WOMAN-2 Trial Collaborators","year":"2024","unstructured":"WOMAN-2 Trial Collaborators. The effect of tranexamic acid on postpartum bleeding in women with moderate and severe anaemia (WOMAN-2): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2024, 404:1645-56. 10.1016\/S0140-6736(24)01749-5","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1800942","article-title":"Tranexamic acid for the prevention of blood loss after vaginal delivery","volume":"379","author":"Sentilhes L","year":"2018","unstructured":"Sentilhes L, Winer N, Azria E, et al.. Tranexamic acid for the prevention of blood loss after vaginal delivery. N Engl J Med. 2018, 379:731-42. 10.1056\/NEJMoa1800942","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028788","article-title":"Tranexamic acid for the prevention of blood loss after cesarean delivery","volume":"384","author":"Sentilhes L","year":"2021","unstructured":"Sentilhes L, S\u00e9nat MV, Le Lous M, et al.. Tranexamic acid for the prevention of blood loss after cesarean delivery. N Engl J Med. 2021, 384:1623-34. 10.1056\/NEJMoa2028788","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-022-04462-z","article-title":"Tranexamic acid for reducing blood loss following vaginal delivery: a double-blind randomized controlled trial","volume":"22","author":"Igboke FN","year":"2022","unstructured":"Igboke FN, Obi VO, Dimejesi BI, Lawani LO. Tranexamic acid for reducing blood loss following vaginal delivery: a double-blind randomized controlled trial. BMC Pregnancy Childbirth. 2022, 22:178. 10.1186\/s12884-022-04462-z","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/373564-tranexamic-acid-in-postpartum-hemorrhage-management-a-multinational-systematic-review-of-efficacy-and-safety-in-both-vaginal-and-cesarean-births","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T16:25:44Z","timestamp":1749572744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/373564-tranexamic-acid-in-postpartum-hemorrhage-management-a-multinational-systematic-review-of-efficacy-and-safety-in-both-vaginal-and-cesarean-births"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.85712","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,10]]}}}